SEC Form 4 · accession 0000914190-18-000348
Cardiovascular Systems Inc · CSII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura Gillund
Officer — Chief Talent Officer
Period of report
Aug 17, 2018
Accepted (ET)
Aug 21, 2018 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180145
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Aug 17, 2018 | S | 2,147 | $37.5555 | D | 87,705 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.44 to $37.6694 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3Includes 273 shares acquired on December 31, 2017 and 946 shares acquired on June 30, 2018 through the Issuer's Employee Stock Purchase Plan.